CCND1 and neoplasm: Tumor samples T32 and T52, which contained CTNNB1 mutations (S45P and S37P), showed elevated CCND1 expression at the critical phosphorylation sites of β‐catenin, which were consistent with increased β‐catenin protein levels in these tumor tissues.